Arkolith/Insider Trading/CADL/Form 4

Nichols William Garrett

Chief Medical OfficerCandel Therapeutics, Inc. (CADL) · full profile →Form 4 · filed Jul 2, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2025Option exercise(M)781$1.29$1K53K
Jun 30, 2025Sell(S)781$5.04$4K52K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2025Option exercise(M)781—$030K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-093035) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML